CAN LYVE-1 MOLECULE BE A DIAGNOSTIC BIOMARKER IN PATIENTS WITH ADVANCED LUNG CANCER?

Abstract

Objective: Primary lung cancers that originate from epithelial cells are classified as carcinomas. Close monitoring of patients with predisposing conditions can enhance early diagnosis rates and facilitate the implementation of therapeutic approaches. LYVE-1 protein is localized to the lymphatic endothelial layer. This study aimed to evaluate the clinical utility of the serum protein and circulating mRNA of LYVE-1 in lung cancer. Materials and Methods: We performed ELISA and Real-time PCR to measure and compare the serum protein and circulating mRNA levels of LYVE-1 in the peripheral blood of 60 patients with advanced lung cancer and 20 controls. Results: Serum LYVE-1 protein and gene expression levels were significantly higher in patients with lung cancer than in controls (p=0.001). There was no association between LYVE-1 (both protein and gene) clinical parameters. The outcome of the ROC analysis, serum LYVE-1 protein (AUC: 0.873) or LYVE-1 gene (AUC: 0.921) in lung cancer patients. Conclusion: As far as we are aware, this study represents the first investigation to compare the protein and mRNA levels of LYVE-1 in the blood samples of lung cancer patients. Additional research involving a larger cohort of subjects will be necessary to gain a deeper understanding of the mechanisms and consequences of LYVE-1 inhibitors in lung cancer.

Keywords

• LYVE-1
• lung cancer
• lymphatic biomarker

LYVE-1 MOLEKÜLÜ İLERİ EVRE AKCİĞER KANSERLİ HASTALARDA TANISAL BİR BİYOBELİRTEÇ OLABİLİR Mİ?

Abstract

Amaç: Primer akciğer kanserleri epitelyal hücrelerden türeyen karsinom lardır. Predispozan bozukluğu olan hastaların yakın takibi, erken tanı ve küratif tedavi yöntemlerinin oranlarında artış sağlayabilir. Hyaluronan için bir reseptör molekülü olan LYVE-1, lenfatik endotelde ifade edilir. Bu çalış ma, akciğer kanserinde LYVE-1’in serum proteini ve dolaşımdaki mRNA’sının klinik faydasını değerlendirmeyi amaçlamıştır. Gereç ve Yöntemler: İleri evre 60 akciğer kanseri hastası ve 20 sağlıklı kontrolün periferik kanında LYVE-1’in serum protein ve dolaşımdaki mRNA seviyelerini ölçmek ve karşılaştırmak için ELISA ve Gerçek Zamanlı PCR uygulaması gerçekleştirildi. Bulgular: Akciğer kanserli hastalarda serum LYVE-1 protein ve gen ekspres yon düzeyleri kontrol grubuna göre anlamlı derecede yüksek bulunmuştur (p=0,001). Akciğer kanseri hastalarında serum LYVE-1 protein ve gen eks presyon düzeyleri ile klinik parametreler arasında bir ilişki bulunmamıştır. ROC analizine göre eğri altında kalan alanlar hesaplandığında; serum LYVE 1 proteini ve geni için AUC (Area Under Curve) değerleri sırasıyla 0,873, 0,921 şeklinde bulunmuştur. Sonuç: Bu çalışma, akciğer kanseri hastalarının kan örneklerinde LYVE-1’in protein ve mRNA düzeylerini karşılaştıran ilk çalışmadır. Akciğer kanserin de LYVE-1 inhibitörlerinin mekanizmalarını ve sonuçlarını daha derinleme sine anlamak için daha geniş bir denek grubunu içeren ek araştırmalara ihtiyaç duyulmaktadır. Bu tür araştırmalar, bu alana ilişkin değerli bilgiler sağlamada faydalı olacaktır.

Keywords

• YVE-1
• akciğer kanseri
• lenfatik biyomarker

References

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30. google scholar
2. Yilmaz S, Dogan Sarikaya M, Yasar E, Sen Burcu B, Canoz O, Onal O. determination of metastatic capacity in primary lung cancer cells: reflection of patient profile in the clinic using in vitro methods. Journal of Advanced Research in Health Sciences 2023;6(3):302-11. google scholar
3. Witte MH, Witte CL. Lymphatics and blood vessels, lymphangiogenesis and hemangiogenesis: from cell biology to clinical medicine. Lymphology 1987;20(4):257-66. google scholar
4. Gerli R, Solito R, Weber E, Agliano M. Specific adhesion molecules bind anchoring filaments and endothelial cells in human skin initial lymphatics. Lymphology 2000;33(4):148-57. google scholar
5. Ryan TJ. Structure and function of lymphatics J Invest Dermatol (Suppl) 1989;93:18-24. google scholar
6. Skobe M, Detmar M. Structure, function, and molecular control of the skin lymphatic system. J Invest Dermatol Symp Proc 2000;5:14-9. google scholar
7. Von Andrian UH, Mempel TR. Homing and cellular traffic in lymph nodes. Nat Rev Immunol 2003;3(11):867-78. google scholar
8. Stacker SA, Achen MG, Jussila L, Baldwin ME, Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2002;2(8):573-83. google scholar

9. Oliver G, Sosa-Pineda B, Geisendorf S, Spana EP, Doe CQ, Gruss P. Prox1, a prospero-related homeobox gene expressed during mouse development. Mech Dev 1993.44(1):3-16. google scholar
10. Nakamura K, Rockson SG. Biomarkers of lymphatic function and disease. Mol Diag Ther 2007;11(4):227-38. google scholar
11. Wigle, JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 1999;98(6):769-78. google scholar
12. Banerji S, Ni J, Wang SX, Su J, Tammi R, Jones M, Jackson DG. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999;144:789-801. google scholar
13. Prevo R, Banerji S, Ferguson D, Jackson DG. Mouse LYVE-1 is an endocytic receptor for hyaluronanin lymphatic endothelium. J Biol Chem 2001;276:19420-30. google scholar
14. Jackson DG. The lymphatics revisited: new perspectives from the hyaluronan receptor LYVE-1. Trends Cardiovasc Med 2003;13:1-7. google scholar
15. Dhama K, Latheef SK, Dadar M, Samad H, Munjal A, Khandia R, et al. Biomarkers in stress related diseases/disorders: diagnostic, prognostic, and therapeutic values. Front Mol Biosci 2019;18:691. google scholar
16. Wishart DS, Bartok B, Oler E, Liang KY, Budinski Z, Berjanskii M, et al. An online database of molecular biomarkers. Nucleic Acids Res 2021;49:D1259-67. google scholar
17. Jauch AS, Wohlfeil SA, Weller C, Dietsch, V, Stojanovic A, Kittel M, et al. Lyve-1 deficiency enhances the hepatic immune microenvironment entailing altered susceptibility to melanoma liver metastasis Cancer Cell Int 2022;22(1):398. google scholar
18. Lim HY, Lim SY, Tan CK, Thiam CH, Goh CC, Carbajo D, et al. Hyaluronan receptor LYVE-1-expressing macrophages maintain arterial tone through hyaluronan-mediated regulation of smooth muscle cell collagen. Immunity 2018;49(6):1191. google scholar
19. Fujimoto A, Ishikawa Y, Akishima-Fukasawa Y, Ito K, Akasaka Y, Maehara S, et al. Significance of lymphatic invasion on regional lymph node metastasis in early gastric cancer using LYVE-1 immunohistochemical analysis. J Clin Pathol 2007;127:82-8. google scholar
20. Wrobel T, Dziegiel P, Mazur G, Zabel M, Kuliczkowski K, Szuba A. LYVE-1 expression on high endothelial venules (HEVs) of lymph nodes. Lymphology 2005;38:107-10. google scholar
21. Carreira CM, Nasser SM, Tomaso E, Padera TP, Boucher Y, Tomarev SI, et al. LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis. Cancer Res 2001;61:8079-84. google scholar
22. Ozmen F, Ozmen M, Ozdemir EM, Moran M, Seçkin S, Guc D, et al. Relationship between LYVE-1, VEGFR-3 and CD44 gene expressions and lymphatic metastasis in gastric cancer. World J Gastroenterol 2011;17:3220-8. google scholar
23. Giatromanolaki A, Sivridis E, Koukourakis MI. Angiogenesis in colorectal cancer: prognostic and therapeutic implications. Am J Clin Oncol 2005;58:202-6. google scholar
24. Nunomiya K, Shibata Y, Abe S, Inoue S, Igarashi A, Yamauchi K, et al. Relationship between serum level of lymphatic vessel endothelial hyaluronan receptor-1 and prognosis in patients with lung cancer J. Cancer 2014;5(3):242-7. google scholar
25. Yoo YA, Kang MH, Lee HJ, Kim B, Park JK, Kim HK, et al. Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer. Cancer Res 2011;71(22):7061-70. google scholar
26. Prevo R, Banerji S, Ferguson DJ, Clasper DS, Jackson DK. Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium. JBC Papers in Press 2001;276(22):19420-30. google scholar
27. Nunomiya K, Shibata, Abe S, Inoue S, Igarashi A, Yamauchi K, et al. Relationship between serum level of lymphatic vessel endothelial hyaluronan receptor-1 and prognosis in patients with lung. Cancer J Cancer 2014;5(3):242-7. google scholar
28. Du Y, Liu H, He Y, Liu Y, Yang C, Zhou M, et al. The interaction between LYVE-1 with hyaluronan on the cell surface may play a role in the diversity of adhesion to cancer cells. PLoS One 2013;8(5). google scholar
29. Shibata MA, Hamaoka H, Kanayama T, Maemura K, Ito Y, Linuma M, et al. Synthetic a-mangostin dilaurate strongly suppresses widespectrum organ metastasis in a mouse model of mammary cancer. Cancer Sci 2018;109(5):1660-71. google scholar
30. PenG LI, Cong Z, Yong Qiang, Lei Xiong, Tang L, Zhang Y, et al. Significance of CCBE1 expression in lung cancer. Mol Med Rep 2018;17(2):2107-12. google scholar